Clinical Trial Update: A Study of SC-007 in Subjects With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of SC-007 in patients with advanced cancer sponsored by AbbVie has been terminated, including colorectal cancer and gastric cancer cohorts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• SC-007

Snippet

Sponsor: AbbVie | Conditions: Colorectal Cancer (CRC), Gastric Cancer | Phase 1 | Status: TERMINATED